KBI Biopharma (KBI), a North Carolina-based biopharmaceutical contract company, is planning a $30 million expansion of its Boulder facility.”These expansions support our vision for growth and create the opportunity to better serve our customers in all areas of the biopharmaceutical industry,” said KBI President Tim Kelly.
Courtesy of Google Image
